Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN107629039B enables high-yield deuterated acrylamide production. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN116640146A reveals efficient palladium-catalyzed route. Delivers high-purity intermediates with scalable manufacturing and substantial cost reduction potential.
Novel FeCl3-catalyzed route for 5-CF3-1,2,4-triazoles enhances purity and scalability for API manufacturing. Discover cost-effective synthesis strategies.
Novel Pd-catalyzed multicomponent method for carbonyl-bridged biheterocycles. Safe, scalable process avoiding toxic CO gas for reliable pharmaceutical intermediate supply.
Novel N,N-coordinated rhodium complex enables high-yield reductive amination. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Novel sulfur-promoted synthesis offers safe scalable production of high-purity triazole intermediates reducing costs and supply chain risks for global pharmaceutical manufacturers.
Patent CN113105401B details a one-pot bimetallic method for symmetrical triazoles. Offers high purity, simplified workflow, and scalable API intermediate production.
Patent CN114591344B reveals a Pd-catalyzed synthesis for chiral spiro compounds. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Efficient three-step synthesis of chroman derivatives using malonate and propargyl bromide. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113087689B reveals a metal-free synthesis for 5-amino-gamma-lactone derivatives. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN113735826B details palladium-catalyzed carbonylation for quinolones. Offers scalable high-purity pharmaceutical intermediates with cost reduction potential.
Novel iodine-promoted method for trifluoromethyl-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN116813544B reveals catalyst-free heating method. Reduces cost and improves supply chain reliability for pharmaceutical intermediates globally with green chemistry.
Novel trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives offering mild conditions and high selectivity for pharmaceutical supply chains.
Patent CN112898192B details a safe, one-pot synthesis of N-acyl indoles using solid CO surrogates, offering significant cost reduction in API manufacturing and scalable production.
Patent CN101935297B reveals a green FeCl3-catalyzed route for 3,3'-diindole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN116640146B reveals efficient Pd-catalyzed synthesis. Delivers high-purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering high efficiency and substrate compatibility for API manufacturing.